Dendritic cells become BCR-ABL negative in chronic myeloid leukaemia patients successfully treated with imatinib [3]

Leukemia

Volumn 18, Issue 5, 2004, Pages 1025-1027

  Wang, L ^a   Butt, N M ^a   Atherton, M G ^b   Clark, R E ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b LIVERPOOL WOMEN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; IMATINIB; INTERFERON; PROTEIN TYROSINE KINASE; ANTINEOPLASTIC AGENT; CD14 ANTIGEN; PIPERAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ADULT; AGED; CANCER PATIENT; CELL FUNCTION; CELLULAR IMMUNITY; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG MECHANISM; ENZYME INHIBITION; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE EXPRESSION; HELPER CELL; HUMAN; LETTER; LEUKEMIA REMISSION; MALE; MONOCYTE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; CHEMISTRY; METABOLISM; MIDDLE AGED;

ADULT; AGED; ANTIGENS, CD14; ANTINEOPLASTIC AGENTS; DENDRITIC CELLS; FEMALE; FUSION PROTEINS, BCR-ABL; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; PIPERAZINES; PYRIMIDINES;

EID: 2342568363     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403342     Document Type: Letter

References (12)

1. Clark RE, Dodi IA, Hill SC, Lill JR, Aubert G, MacIntyre AR et al. Direct evidence that leukaemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein. Blood 2001; 98: 2887-2893.
2. Choudhury A, Gajewski JL, Liang JC, Popat U, Claxton DF, Kliche KO et al. Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia. Blood 1997; 89: 1133-1142.
3. Eibl B, Ebner S, Duba C, Bock G, Romani N, Erdel M et al. Dendritic cells generated from blood precursors of chronic myelogenous leukemia patients carry the Philadelphia translocation and can induce a CML-specific primary cytotoxic T-cell response. Genes Chromosomes Cancer 1997; 20: 215-223.
4. Smit WM, Rijnbeek M, van Bergen CA, de Paus RA, Vervenne HA, van de Keur M et al. Generation of dendritic cells expressing BCR-ABL from CD34-positive chronic myeloid leukemia precursor cells. Hum Immunol 1997; 53: 216-223.
5. Jiang YZ, Mavroudis D, Dermime S, Hensel N, Couriel D, Molldrem J et al. Alloreactive CD4+ T lymphocytes can exert cytotoxicity to chronic myeloid leukaemia cells processing and presenting exogenous antigen. Br J Haematol 1996; 93: 606-612.
6. Dong R, Cwynarski K, Entwistle A, Marelli-Berg F, Dazzi F, Simpson E et al. Dendritic cells from CML patients have altered actin organization, reduced antigen processing, and impaired migration. Blood 2003; 101: 3560-3567.
7. Wang C, Al-Omar HM, Radvanyi L, Banerjee A, Bouman D, Squire J et al. Clonal heterogeneity of dendritic cells derived from patients with chronic myeloid leukemia and enhancement of their T-cells stimulatory activity by IFN-α. Exp Hematol 1999; 27: 1176-1184.
8. O'Brien SG, Guilhot F, Larson RA, Gathmann I, Baccarani M, Cervantes F et al. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 2003; 348: 994-1004.
9. Wang L, Pearson K, Pillitteri L, Ferguson JE, Clark RE. Serial monitoring of BCR-ABL by peripheral blood real time polymerase chain reaction predicts the marrow cytogenetic response to imatinib mesylate in chronic myeloid leukaemia. Br J Haematol 2002; 118: 771-777.
10. Auffermann-Gretzinger S, Lossos IS, Vayntrub TA, Leong W, Grumet FC, Blume KG et al. Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients. Blood 2002; 99: 1442-1448.
11. Dietz AB, Bulur PA, Erickson MR, Wettstein FJ, Litzow MR, Wyatt WA et al. Optimizing preparation of normal dendritic cells and BCR-ABL positive mature dendritic cells derived from immuno-magnetically purified CD14 positive cells. J Hematother Stem Cell Res 2000; 9: 95-101.
12. Mohty M, Jourdan E, Ben Mami N, Vey N, Damaj G, Blaise D et al. Imatinib and plasmacytoid dendritic cell function in chronic myeloid leukemia patients. Blood 2004, Jan 8 [Epub ahead of print].